Company profile for Cosmo Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cosmo’s therapeutic focus is on the oral and endoscopic treatment of colon diseases. Many colon diseases are recurring, some are chronic. This means that their treatment by systemic route bears the risk of serious side effects which is why Cosmo focuses on treating these diseases either orally with tablets or by endoscopic applications. Cosmo Pharmaceuticals has developed over the years a significant manufacturing know-how. ...
Cosmo’s therapeutic focus is on the oral and endoscopic treatment of colon diseases. Many colon diseases are recurring, some are chronic. This means that their treatment by systemic route bears the risk of serious side effects which is why Cosmo focuses on treating these diseases either orally with tablets or by endoscopic applications. Cosmo Pharmaceuticals has developed over the years a significant manufacturing know-how. We provide services related to the industrial manufacturing of pharmaceutical products such as assessment and set-up of manufacturing processes, evaluation of pharmaceutical products’ stability.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
Riverside II Sir John Rogerson’s Quay Dublin 2
Telephone
Telephone
+ 353 1 817 0370
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/cosmo-shares-zoom-results-2-male-pattern-hair-loss-trials

FIERCE PHARMA
03 Dec 2025

https://www.expresspharma.in/cosmo-and-glenmark-receives-market-authorization-for-winlevi-in-europe/

EXPRESSPHARMA
18 Nov 2025

https://www.business-standard.com/companies/news/glenmark-cosmo-get-mhra-nod-to-market-acne-treatment-medication-in-uk-125021000609_1.html

BUSSINESS STD
10 Feb 2025

https://www.prnewswire.com/news-releases/cosmo-and-glenmark-announce-the-signing-of-distribution-and-license-agreements-for-winlevi-in-europe-and-south-africa-301940026.html

PR NEWSWIRE
27 Sep 2023

https://www.prnewswire.com/news-releases/hyphens-pharma-licenses-winlevi-for-all-10-asean-countries-from-cosmo-pharmaceuticals-301709496.html

PR NEWSWIRE
23 Dec 2022

https://www.expresspharma.in/sun-pharma-and-cosmo-announce-territory-expansion-of-license-and-supply-agreements-for-winlevi/

EXPRESS PHARMA
26 Jul 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty